DeutschNewstral
Article
The New York Times on 2024-04-19 22:06
Sleep apnea reduced in people who took weight-loss drug, Eli Lilly reports
Related news
- Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly ReportsThe New York Times
Weight Loss Drug Zepbound May Reduce Sleep Apnea, Eli Lilly SaysForbes
Eli Lilly & Co: Eli Lilly weight-loss drug found to address sleep apnoea in trialFinancial Times- MEli Lilly expects FDA name on Zepbound for sleep apnea in close to time periodmvtelegraph.com
Lilly: Weight-loss drug resolves sleep apnea in up to 52% of patientsstaradvertiser.com- A new option to treat sleep apnea: Weight-loss drugsThe New York Times
- A new option to treat sleep apnea: weight-loss drugsThe New York Times
- TWeight loss drug could help treat sleep apnea: Studythehill.com
- FEli Lilly & Co: Eli Lilly launches cut-price version of blockbuster weight-loss drugft.com
- Eli Lilly & Co: Eli Lilly to invest extra $5.3bn in manufacturing site for weight loss drugsFinancial Times
- FEli Lilly & Co: Eli Lilly lifts outlook on bumper sales of diabetes and weight loss drugsft.com
- Eli Lilly & Co: Eli Lilly to seek obesity drug approval that could disrupt weight loss marketFinancial Times
Eli Lilly weight loss drug Zepbound approved by the FDANew York Post- DEli Lilly slumps after disappointing Zepbound weight-loss-drug trialdcourier.com
- MEli Lilly weight reduction drug tirzepatide knowledge launchedmvtelegraph.com
- MEli Lilly releases new, cheaper type of weight reduction drugmvtelegraph.com
Diabetes, weight drugs earn Eli Lilly $4B in 2Qnwaonline.com- FEli Lilly & Co: Eli Lilly races to boost capacity for rival to Novo Nordisk weight-loss drugft.com
Diet changes can improve sleep apnea, even without weight loss - Thu, 17 Nov 2022 PSTThe Spokesman-Review